For patients
Care without confirmation.
Barriers to affordable, convenient care can encourage self medication and delay care. Limited testing can leave treatment guided by symptoms or assumptions rather than diagnostic evidence.
Research & developmentIn development. No prototype or clinical services available yet.
CarmensaYour Personal
AI Agent for
Better Diagnostic
Decisions.
From ordering diagnostic tests to understanding results and coordinating follow up testing, our proposed AI Agent aims to help patients and healthcare professionals make informed decisions and take action.
The diagnostic gap
When healthcare decisions
lack evidence.
Diagnostic testing is fundamental to modern medicine. Yet too many patients and clinicians lack the information they need.
The access gap: Lancet Commission, 2021
Approximately 81% lacked access to the simplest primary care diagnostic tests.
In countries with low and lower middle incomes, only about 19% had access to these tests, excluding tests for HIV and malaria.
For clinicians
Decisions under uncertainty.
Without timely, reliable results, clinicians face greater diagnostic uncertainty, with risks of missed diagnoses, inappropriate treatment, and delayed intervention. Medical brain drain adds further pressure.
Carmensa Health aims to help close this gap through a personal AI diagnostic agent: making testing more accessible, results easier to understand, and evidence informed decisions more achievable.
Evidence: Lancet Commission on Diagnostics (2021); antibiotic self medication reviews (2023) and (2025).
Our purpose
Better diagnostic decisions.
More equitable care.
Mission
To empower patients and clinicians with intelligent technologies that enhance decision making, strengthen healthcare delivery, and improve patient outcomes in resource-limited countries.
Vision
We are imagining a future where our technology evolves into a super intelligent AI that amplifies clinical judgment, personalizes decisions, and continuously adapts to new knowledge, ensuring quality healthcare is accessible to everyone.
The promise of AI
Amplify expertise.
Support human decisions.
Relevant knowledge.
Bring useful clinical information closer to the point of care.
Clearer results.
Help patients and clinicians understand diagnostic information.
Connected next steps.
Support informed decisions and follow up coordination.
Research ambitions, not proven capabilities. AI complements clinicians and essential testing.
Research & development: Liberia
Understand the gaps.
Build around real needs.
Trillion Cells is seeking clearance and institutional collaboration for an on site study in Liberia to identify diagnostic decision making challenges.
Access to testing.
Availability, affordability, and logistics.
Support for clinicians.
Expertise, tools, and diagnostic uncertainty.
Priorities for AI.
Where intelligent systems could help most.
Proposed study: Clearance and collaboration being soughtNo approved or active study, prototype, or clinical service is announced.
Our starting point